Literature DB >> 17761365

Ursodeoxycholic acid intervention in patients with familial adenomatous polyposis: a pilot study.

Marloes Berkhout, Hennie M J Roelofs, Pieter Friederich, Annie van Schaik, Marleen J E M Gosens, Brigitte Marian, Beatrice L Pool-Zobel, J Han J M van Krieken, Wilbert H M Peters, Fokko M Nagengast.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17761365     DOI： 10.1016/j.trsl.2007.03.009

Source DB:  PubMed          Journal:  Transl Res        ISSN： 1878-1810            Impact factor:   7.012


× No keyword cloud information.
  5 in total

1.  Colonic interposition in a woman with attenuated familial adenomatosis polyposis: does the location of the colon affect polyp formation?

Authors:  Melanie D Beaton; Brian Taylor; David Driman; Peter Ainsworth; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2008-07       Impact factor: 3.522

2.  "High rate of recurrent adenomatosis during endoscopic surveillance after duodenectomy in patients with familial adenomatous polyposis".

Authors:  Yasser A Alderlieste; Barbara A Bastiaansen; Elisabeth M H Mathus-Vliegen; Dirk J Gouma; Evelien Dekker
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

3.  Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.

Authors:  Yong Zhang; Hao Liu; Li Li; Min Ai; Zheng Gong; Yong He; Yunlong Dong; Shuanglan Xu; Jun Wang; Bo Jin; Jianping Liu; Zhaowei Teng
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

4.  Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial.

Authors:  Bjorn W H van Heumen; Hennie M J Roelofs; M Elisa Vink-Börger; Evelien Dekker; Elisabeth M H Mathus-Vliegen; Jan Dees; Jan J Koornstra; Alexandra M J Langers; Iris D Nagtegaal; Ellen Kampman; Wilbert H M Peters; Fokko M Nagengast
Journal:  Orphanet J Rare Dis       Date:  2013-08-06       Impact factor: 4.123

5.  Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.

Authors:  Bjorn W H van Heumen; Hennie M J Roelofs; René H M te Morsche; Fokko M Nagengast; Wilbert H M Peters
Journal:  Orphanet J Rare Dis       Date:  2013-11-19       Impact factor: 4.123
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.